Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
16-Nov-26
$200m
$200mEST
31-Dec-28
Second 2026 share repurchase program authorized to repurchase up to $200.0 million of outstanding common stock through 20288-K filed 16-Nov-26